Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-26-005852
Filing Date
2026-01-07
Accepted
2026-01-07 11:53:39
Documents
1
Effectiveness Date
2026-01-07

Document Format Files

Seq Description Document Type Size
1 S-8 POS d21530ds8pos.htm S-8 POS 33638
  Complete submission text file 0001193125-26-005852.txt   34825
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-228282 | Film No.: 26514712
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)